Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danqi Tongluo Fang (also known as Danqi Tongluo Recipe) is a traditional Chinese medicine (TCM) formulation investigated for its therapeutic potential in musculoskeletal disorders, particularly cervical spondylosis and lumbar disc herniation. This complex herbal mixture comprises numerous active components, including quercetin, beta-sitosterol, stigmasterol, kaempferol, luteolin, ferulic acid, and tanshinone. Research utilizing network pharmacology has identified that the formulation acts through a multi-target, multi-pathway mechanism. Key biological targets include HSPA8, RPS27A, RPS27, and STAU1, which are involved in signaling pathways such as the MAPK and Wnt pathways. These interactions suggest that Danqi Tongluo Fang may help modulate inflammation and cellular stress responses associated with degenerative spinal conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Danqi Tongluo Fang.